News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
2,886 Results
Type
Article (26)
Press Release (2860)
Section
Business (1333)
Career Advice (2)
Deals (180)
Drug Development (631)
FDA (95)
Job Trends (267)
News (2103)
Policy (116)
Tag
Academia (3)
Alliances (39)
Alzheimer's disease (26)
Approvals (99)
Artificial intelligence (1)
Bankruptcy (1)
Best Places to Work (290)
Breast cancer (2)
Cancer (20)
Career advice (1)
Clinical research (600)
Collaboration (4)
Compensation (1)
COVID-19 (4)
Data (36)
Diabetes (1)
Diagnostics (19)
Earnings (1345)
Events (315)
FDA (106)
Frontotemporal dementia (1)
Funding (1)
Generative AI (1)
Gene therapy (3)
GLP-1 (8)
Government (8)
Healthcare (85)
Infectious disease (4)
Inflammatory bowel disease (2)
IPO (160)
Job creations (1)
Job search strategy (1)
Kidney cancer (1)
Layoffs (1)
Legal (1)
Lung cancer (11)
Manufacturing (1)
MASH (1)
Medical device (56)
Medtech (56)
Mergers & acquisitions (22)
Metabolic disorders (3)
Multiple sclerosis (2)
NASH (1)
Neuroscience (31)
NextGen Class of 2024 (8)
Non-profit (4)
Northern California (18)
Obesity (1)
People (8)
Phase I (90)
Phase II (181)
Phase III (352)
Pipeline (22)
Postmarket research (27)
Preclinical (11)
Prostate cancer (2)
Radiopharmaceuticals (6)
Rare diseases (2)
Regulatory (123)
Reports (2)
Research institute (6)
Resumes & cover letters (1)
Schizophrenia (2)
Southern California (7)
Startups (3)
United States (148)
Vaccines (2)
Date
Today (2)
Last 7 days (13)
Last 30 days (70)
Last 365 days (412)
2024 (388)
2023 (423)
2022 (418)
2021 (481)
2020 (310)
2019 (202)
2018 (150)
2017 (116)
2016 (39)
2015 (73)
2014 (43)
2013 (25)
2012 (28)
2011 (23)
2010 (22)
Location
Asia (316)
Australia (12)
California (25)
Canada (9)
China (2)
Delaware (9)
Europe (570)
Florida (4)
Georgia (2)
Illinois (1)
Indiana (11)
Japan (3)
Maryland (6)
Massachusetts (21)
Minnesota (1)
New Jersey (23)
New York (17)
North Carolina (6)
Northern California (18)
Ohio (2)
Pennsylvania (14)
South America (5)
Southern California (7)
Texas (3)
Utah (4)
Washington State (2)
2,886 Results for "%E2%80%9D%20target=".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Enterome to Host Webinar on New Clinical Data From the Ongoing Phase 1/2 ‘SIDNEY’ Trial of Lead Programme, EO2463
November 13, 2024
·
4 min read
Press Releases
Almirall’s Nine-Month 2024 Results: Almirall Reports Strong Performance at Q3 2024 - Driven by Successful Commercial Execution of the Dermatology Portfolio, Fuelled by Biologics Growth
November 11, 2024
·
7 min read
Press Releases
Vertex Reports Third Quarter 2024 Financial Results
November 4, 2024
·
19 min read
Press Releases
Arrowhead Pharmaceuticals Launches New Disease Awareness Campaign, ‘We’ll Get There Soon,’ to Inspire Hope for the Rare Disease Community Affected by Familial Chylomicronemia Syndrome
November 4, 2024
·
6 min read
Press Releases
Cognito Therapeutics Announces Spectris™ Treatment Demonstrates 56.4% Reduction in Alzheimer’s Disease Dependence Score with Strong Safety Profile
October 29, 2024
·
4 min read
Press Releases
Cellectar Biosciences Reports Financial Results for Q3 2024 and Provides a Corporate Update
November 18, 2024
·
10 min read
Press Releases
e-therapeutics Announces Business Updates and Interim Results
October 31, 2024
·
11 min read
Press Releases
Regeneron Reports Third Quarter 2024 Financial and Operating Results
October 31, 2024
·
30 min read
Press Releases
Coya Therapeutics Announces Positive Results of a Double-Blind Study of Subcutaneous Low-Dose Interleukin-2 (LD IL-2) in Alzheimer’s Disease (AD) Presented at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24) in Madrid (Spain)
October 29, 2024
·
18 min read
Press Releases
Silence Therapeutics Presents Late-Breaking Phase 2 Zerlasiran Data at 2024 American Heart Association (AHA) Annual Meeting
November 18, 2024
·
7 min read
1 of 289
Next
